Connect with us

Healthcare

White House gets away from press briefing without any questions about Fauci’s emails

Published

on

Screen Shot 2021 06 02 at 4.52.36 PM scaled

Following the release of emails from Dr. Anthony Fauci from the early days of the pandemic Tuesday, not a single White House correspondent asked Press Secretary Jen Psaki about the emails during the entire Wednesday briefing. Instead, they mostly discussed cyberattacks from Russia and national cybersecurity.

Newsmax White House correspondent Emerald Robinson expressed her own disappointment on Twitter. She wrote “not even one reporter today in the press pool . . .had the courage to ask.”

Caleb Hull tweeted his bleak opinion about the state of the industry as a whole. “Journalism is dead,” he wrote.

Senior congressional correspondent for The Daily Caller Henry Rodgers agreed, saying it was “honestly insane” to hear that not a single reporter asked about the emails. “Tells you everything you need to know,” Rodgers tweeted.

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

You may like

Continue Reading

Healthcare

TN Republican introduces legislation to fight opioid shipments into U.S.

Published

on

Fentanyl 1031234188 scaled

Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:

The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.

“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”

“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.

The Daily Caller reports:

According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.

The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.

Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC